Literature DB >> 21324342

Insights into the B cell specific process of immunoglobulin class switch recombination.

Sven Kracker1, Anne Durandy.   

Abstract

Antibody maturation leads to the formation of B cell receptors (BCRs) with high affinity for antigen and the production of different Ig isotypes. The different antibody isotypes vary in activities (half-life, binding to Fc receptors, ability to activate the complement system) and tissue localization and thus are necessary for an optimal humoral response against pathogens. The molecular mechanism responsible for exchanging the Ig isotypes (IgM to IgG, IgA, or IgE) and at the same time retaining the antigen specificity and affinity is called Ig class switch recombination (CSR). In this review we discuss the molecular mechanism of CSR, with special focus on the enzyme activation induced cytidine deaminase (AID).
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324342     DOI: 10.1016/j.imlet.2011.02.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.

Authors:  Andrew D Vonberg; Maria Acevedo-Calado; Aaron R Cox; Susan L Pietropaolo; Roberto Gianani; Steven K Lundy; Massimo Pietropaolo
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

3.  The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated γH2AX Formation.

Authors:  Shaliny Ramachandran; Dania Haddad; Conglei Li; Michael X Le; Alexanda K Ling; Clare C So; Rajeev M Nepal; Jennifer L Gommerman; Kefei Yu; Troy Ketela; Jason Moffat; Alberto Martin
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

Review 4.  AIDing antibody diversity by error-prone mismatch repair.

Authors:  Richard Chahwan; Winfried Edelmann; Matthew D Scharff; Sergio Roa
Journal:  Semin Immunol       Date:  2012-06-14       Impact factor: 11.130

Review 5.  Diverse immune evasion strategies by human cytomegalovirus.

Authors:  Vanessa Noriega; Veronika Redmann; Thomas Gardner; Domenico Tortorella
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

6.  B cell-specific deficiencies in mTOR limit humoral immune responses.

Authors:  Shuling Zhang; Margaret Pruitt; Dena Tran; Wendy Du Bois; Ke Zhang; Rushi Patel; Shelley Hoover; R Mark Simpson; John Simmons; Joy Gary; Clifford M Snapper; Rafael Casellas; Beverly A Mock
Journal:  J Immunol       Date:  2013-07-15       Impact factor: 5.422

7.  A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants.

Authors:  Yunxiang Mu; Courtney Prochnow; Phuong Pham; Xiaojiang S Chen; Myron F Goodman
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

8.  DNA repair genotype and lung cancer risk in the beta-carotene and retinol efficacy trial.

Authors:  Jennifer A Doherty; Lori C Sakoda; Melissa M Loomis; Matt J Barnett; Liberto Julianto; Mark D Thornquist; Marian L Neuhouser; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Int J Mol Epidemiol Genet       Date:  2013-03-18

Review 9.  AID and Apobec3G haphazard deamination and mutational diversity.

Authors:  Malgorzata Jaszczur; Jeffrey G Bertram; Phuong Pham; Matthew D Scharff; Myron F Goodman
Journal:  Cell Mol Life Sci       Date:  2012-11-22       Impact factor: 9.261

10.  Epitope predictions indicate the presence of two distinct types of epitope-antibody-reactivities determined by epitope profiling of intravenous immunoglobulins.

Authors:  Mitja Luštrek; Peter Lorenz; Michael Kreutzer; Zilliang Qian; Felix Steinbeck; Di Wu; Nadine Born; Bjoern Ziems; Michael Hecker; Miri Blank; Yehuda Shoenfeld; Zhiwei Cao; Michael O Glocker; Yixue Li; Georg Fuellen; Hans-Jürgen Thiesen
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.